07 3435 5000
1300 852 853


Epilepsy Queensland is often contacted by hospitals and universities seeking participants in research studies.

We recognise the vital role of high-quality research for improving the lives of people living with epilepsy and their families and carers. Evidence-based epilepsy research informs clinical practice, policy, education and training. Epilepsy Queensland shares current research opportunities on this page related to medication trials, treatment options, assistive devices and the impact of epilepsy.

We encourage you to check here regularly for a list of research projects being undertaken. You can also subscribe to our eNews to learn more about research. 

To support epilepsy research and for information or expressions of interest call us on 07 3435 5000.

Current Research Opportunities

Mater Research is looking for people with focal epilepsy

Mater Research is looking for people aged 18 and over across Queensland with focal (partial) epilepsy who still have ongoing seizures despite having tried two or more anti-seizure medications.

The study will be conducted over a period of three years with patient participation required for six months and require some medical testing.

If you are interested in participating or would like further information please contact,

Epilepsy Care in the Genomic Era

Queensland Genomics has funded a clinical project Integrating Epilepsy Genomics into Clinical Care aimed at patients with refractory epilepsy; where the seizures are not able to be controlled by medications.

The project will seek to find answers to two crucial questions for patients: ‘What is the cause of my epilepsy?’ and ‘How can my epilepsy be treated?’ Led by neurologist Associate Professor Lata Vadlamudi, the project team will work to incorporate genomic testing into the healthcare for eligible patients with refractory epilepsy at Royal Brisbane and Women’s Hospital, Queensland Children’s Hospital and Cairns Base Hospital.

With this new technology and the discovery of new genes associated with epilepsy, studies like this will enable a deeper understanding of the causes of epilepsy, which will ultimately drive the search for more effective drug treatments for patients.

The goal of including genomics in epilepsy healthcare is to improve the quality of care for patients and their families, and improve efficiencies in healthcare.

For more information if you are interested in participating,  please see the information sheet below.